Editor: Atta-ur-Rahman FRS

Frontiers in Clinical Drug Research-Hematology

Volume 3

eBook: US $100 Special Offer (PDF + Printed Copy): US $168
Printed Copy: US $119
Library License: US $400
ISSN: 2467-9585 (Print)
ISSN: 2352-3239 (Online)
ISBN: 978-1-68108-368-1 (Print)
ISBN: 978-1-68108-367-4 (Online)
Year of Publication: 2018
DOI: 10.2174/97816810836741180301

Introduction

Frontiers in Clinical Drug Research – Hematology is a book series that brings updated reviews to readers interested in learning about advances in the development of pharmaceutical agents for the treatment of hematological disorders. The scope of the book series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of natural and synthetic drugs employed in the treatment of anemias, coagulopathies, vascular diseases and hematological malignancies. Reviews in this series also include research on specific antibody targets, therapeutic methods, genetic hemoglobinopathies and pre-clinical / clinical findings on novel pharmaceutical agents. Frontiers in Clinical Drug Research – Hematology is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in the field of hematology, oncology and vascular pharmacology.

The third volume of this series features 6 reviews:

  • - Advances in the understanding and treatment of immune thrombocytopenia
  • - Recent developments in chronic myeloid leukemia biology and treatment
  • - Role of immunomodulatory drugs in the treatment of lymphoid and myeloid malignancies
  • - Pediatric hematological malignancies – clinical manifestation, treatment and follow-up
  • - Novel therapies and immunotherapeutic approaches to treat childhood leukemia
  • - Erythrocyte turnover and erythropoietic patterns in two different experimental mouse models of anemia

Contributors

Editor(s):
Atta-ur-Rahman FRS
Honorary Life Fellow
Kings College
University of Cambridge
Cambridge
UK




Contributor(s):
Claudio Sorio
Section of General Pathology, Department of Medicine
University of Verona
Italy


José Perdomo
Haematology Research Unit, St George and Sutherland Clinical School
University of New South Wales
Australia


Krishna Kanth Pulicherla
Department of Science and Technology, Ministry of Science and Technology, Govt. of India, Technology Bhavan, New Mehrauli Road
New Delhi-110016
India


Massimiliano Bonifacio
Section of Hematology, Department of Medicine
University of Verona
Italy


Naga Ramya Lanka
Acharya Nagarjuna University
Nagarjuna Nagar, Guntur-522510
India


Natasha Ali
Department of Pathology & Laboratory Medicine/Oncology, Aga Khan University
Karachi
Pakistan


Ota Fuchs
Institute of Hematology and Blood Transfusion
U Nemocnice 1, 128 20 Prague 2
Czech Republic


Rajiv K. Saxena
Faculty of Life Sciences and Biotechnology, South Asian University
New Delhi
India


Sreoshi Chatterjee
School of Life Sciences, Jawaharlal Nehru University
New Delhi
India




RELATED BOOKS

.Natural Products in Clinical Trials.
.Good Quality Practice (GQP) in Pharmaceutical Manufacturing: A Handbook.
.Natural Products in Clinical Trials.
.Advances in Physicochemical Properties of Biopolymers: Part 1.
.Frontiers in Clinical Drug Research-Hematology.
.Frontiers in Clinical Drug Research-Hematology.
.The Spleen.